MARTIN & LEMIS AGAR W/VCAT INHIBITOR— 510(k) K823309

Name: FDA 510(k) clearance K823309
Creator: U.S. Food and Drug Administration
Published: 1982-12-03

Substantially Equivalent

Troy Biologicals, Inc.

FDA 510(k) clearance K823309 for MARTIN & LEMIS AGAR W/VCAT INHIBITOR, Substantially Equivalent on 1982-12-03. Applicant: Troy Biologicals, Inc.. Device class: 2.

Clearance details

Applicant: Troy Biologicals, Inc.
Product code: Code JTY
Device class: Class 2
Regulation: 21 CFR 866.2410
Advisory panel: Microbiology
Date received: 1982-11-05
Decision date: 1982-12-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JTY

view all

K210511 — InTray GC2021-10-20
K993033 — INTRAY GC1999-12-16
K954986 — GC BASE W/ 1% GCHI1996-02-16
K950196 — CULTURE MEDIA, FOR ISOLATION OF PATHOGENIC NEISSERIA1995-06-30
K933122 — MICROBIOLOGICAL CULTURE MEDIA,MARTIN LEWIS AGAR1994-02-09

More clearances from Troy Biologicals, Inc.

view all

K861301 — BACTI PLATE (DERMATOLOGY) PRODUCT NO. PS-50001986-04-21
K832860 — SXT BLOOD AGAR1983-09-26
K832861 — SABOURAUD DEXTROSE AGAR1983-09-26
K832862 — TRANSGROW MEDIUM1983-09-26
K832863 — STREP ID QUAD1983-09-26

Data sourced from openFDA. This site is unofficial and independent of the FDA.